Skip to main content
Top
Literature
1.
go back to reference Deprez S, Amant F, Yigit R, et al. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp. 2011;32:480–93.PubMedCrossRef Deprez S, Amant F, Yigit R, et al. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp. 2011;32:480–93.PubMedCrossRef
2.
go back to reference Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol. 2012;20(30):274–81.CrossRef Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol. 2012;20(30):274–81.CrossRef
Metadata
Title
Erratum to: Chemotherapy-Related Cognitive Dysfunction
Authors
Jeffrey S. Wefel
Sanne B. Schagen
Publication date
01-06-2012
Publisher
Current Science Inc.
Published in
Current Neurology and Neuroscience Reports / Issue 3/2012
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-012-0271-x

Other articles of this Issue 3/2012

Current Neurology and Neuroscience Reports 3/2012 Go to the issue

Neuro-Oncology (LE Abrey, Section Editor)

Temozolomide Dosing Regimens for Glioma Patients

Genetics (V Bonifati, Section Editor)

Recent Advances in the Genetics of the ALS-FTLD Complex